Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-60
SponsorGødstrup Hospital

About this trial

The goal of this case-control study is to pave the way for new revolutionary treatment measures within hearing loss that could either replace or delay the need for hearing aids. The study focuses on people with Turner syndrome (TS).

The aim is to find out if there are specific DNA methylation patterns and/or RNA expression profiles linked to sensorineural hearing loss (SNHL) in people with TS. Additionally, the structure and function of the inner ear in these individuals will be examined to see if there is a connection to their epigenetic profile.

The main question it aims to answer is: Does epigenetics constitute a common denominator for some of the unexplained SNHL cases?

Turner Syndrome (TS) represents an ideal model for studying epigenetics related to sensorineural hearing loss (SNHL).

Participants will undergo the following tests:

* Ear examinations * Hearing tests * Balance tests * Blood tests * MRI scans * CBCT (cone-beam computed tomography) scans

Eligibility criteria

Qualifiers

age between 18 and 60 years old

Disqualifiers

Contraindications for the MRI or CBCT

Serious medical disorders

Neurological or psychiatric disorders of any kind

Use of medication that is known to influence inner ear function

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Gødstrup Hospital

Lead sponsor

University of Aarhus

Collaborator

Aarhus University Hospital

Collaborator